Working...
ClinicalTrials.gov
ClinicalTrials.gov Menu

A Study to Evaluate the Impact of Maintaining Hemoglobin Levels Using Epoetin Alfa in Patients With Metastatic Breast Cancer Receiving Chemotherapy

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00211133
Recruitment Status : Completed
First Posted : September 21, 2005
Last Update Posted : November 30, 2010
Sponsor:
Information provided by:
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.